Home › Free Stock Grades › IMMX
Immix Biopharma, Inc. (IMMX) Stock Grade
IMMX · Healthcare
B
Market Cap
$172.4M
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Immix Biopharma, Inc.'s fundamentals
Immix Biopharma is a biotechnology company with a market capitalization of $172.4 million that reported zero revenue growth year-over-year and operates at a net margin of 0.0% while carrying a net loss in its latest annual statement. The company pays no dividend and does not have calculable profitability metrics, reflecting its pre-revenue or early-stage development status typical of many biotechnology firms focused on pipeline advancement rather than current earnings.